Somnair Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 16

Somnair General Information

Description

Developer of a non-invasive neurostimulation device intended for the treatment of obstructive sleep apnea. The company's platform delivers therapy that targets the root neurological causes of airway obstruction without surgical intervention, is deployable in a home setting, enabling healthcare providers to access a potentially more accessible, patient-friendly alternative to traditional continuous positive airway pressure or implant-based therapies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 307 Washington Avenue
  • Baltimore, MD 21204
  • United States
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Corporate Office
  • 307 Washington Avenue
  • Baltimore, MD 21204
  • United States

Somnair Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Somnair Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
16. Secondary Transaction - Private 31-Mar-2026 Completed Pre-Clinical Trials
15. Seed Round 07-Jul-2025 Completed Pre-Clinical Trials
14. Accelerator/Incubator 24-Jun-2025 Completed Pre-Clinical Trials
13. Grant 03-Jun-2025 Completed Pre-Clinical Trials
12. Accelerator/Incubator 30-Sep-2024 Completed Pre-Clinical Trials
11. Grant 08-Apr-2024 Completed Pre-Clinical Trials
10. Grant 16-Feb-2024 Completed Pre-Clinical Trials
9. Accelerator/Incubator 01-Jan-2024 Completed Pre-Clinical Trials
8. Accelerator/Incubator 26-Jul-2023 $5K $5K Completed Pre-Clinical Trials
7. Grant 16-May-2023 $5K Completed Pre-Clinical Trials
To view Somnair’s complete valuation and funding history, request access »

Somnair Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Pre-Seed-1
Pre-Seed
To view Somnair’s complete cap table history, request access »

Somnair Patents

Somnair Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024301234-A1 Methods and systems for treating sleep disordered breathing Pending 24-Jul-2023
EP-4750523-A1 Methods and systems for treating sleep disordered breathing Pending 24-Jul-2023
WO-2025024561-A1 Methods and systems for treating sleep disordered breathing Inactive 24-Jul-2023 A61F5/566

Somnair Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Somnair Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
HopStone Capital Venture Capital Minority
J2 Ventures Venture Capital Minority
Jumpspace Ventures Venture Capital Minority
MedStar Health Corporation Minority
Wolf Point Capital Venture Capital Minority
You’re viewing 5 of 16 investors. Get the full list »

Somnair FAQs

  • When was Somnair founded?

    Somnair was founded in 2022.

  • Where is Somnair headquartered?

    Somnair is headquartered in Baltimore, MD.

  • What is the size of Somnair?

    Somnair has 6 total employees.

  • What industry is Somnair in?

    Somnair’s primary industry is Therapeutic Devices.

  • Is Somnair a private or public company?

    Somnair is a Private company.

  • What is Somnair’s current revenue?

    The current revenue for Somnair is .

  • How much funding has Somnair raised over time?

    Somnair has raised $4.33M.

  • Who are Somnair’s investors?

    HopStone Capital, J2 Ventures, Jumpspace Ventures, MedStar Health, and Wolf Point Capital are 5 of 16 investors who have invested in Somnair.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process